A. Lenting
Papers
2
Total Citations
10
H-Index
2
About
A. Lenting is a surgical oncologist whose research focuses on improving outcomes for patients with bladder cancer, particularly through the comparative evaluation of surgical techniques. Their major contributions center on assessing the intermediate-term survival of robot-assisted radical cystectomy (RARC) versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer. Using data from the Netherlands, Lenting’s work provides critical evidence that RARC offers non-inferior oncological outcomes compared to the traditional open approach, with potential benefits in recovery and complication rates. Their most-cited paper (2021, 8 citations) established this non-inferiority in intermediate-term survival, while a follow-up study (2021, 2 citations) reinforced these findings. This research has significant implications for surgical decision-making, helping to validate the adoption of robotic techniques in complex urological oncology. By leveraging national registry data, Lenting’s work contributes to evidence-based guidelines and offers reassurance to surgeons and patients considering minimally invasive options for bladder cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2